EDBI is the dedicated corporate investment arm of the Singapore Economic Development Board (EDB). It deploys multi-billion-dollar capital into growth-stage technology and biotech companies worldwide, with the explicit twin mandate of generating financial returns and anchoring strategic technology assets, regional HQs, R&D centres, manufacturing plants, in Singapore.
For founders, EDBI typically participates at Series B and later, often as a single $20 to 80M cheque in a $100M+ round. The trade-off: EDBI capital is paired with a 'Singapore commitment', opening or expanding a Singapore office, hiring meaningful local headcount, sometimes locating IP in Singapore. EDBI has a strong record of opening doors to Singapore's broader ecosystem of corporates, sovereign LPs, and government R&D programmes.